PT Bundamedik TbkISX:BMHS +1.75%60 OCF Yield % is 15.00 as of Jul. 06, 2026, which is 405% above its 10-year median of 2.97. GuruFocus rates ISX:BMHS with a GF Score™ of 60/100 and a GF Value™ of Rp306.02 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 681 Healthcare Providers & Services companies, PT Bundamedik Tbk ranks better than 81.35% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for PT Bundamedik Tbk's OCF Yield % or its related term are showing as below:
ISX:BMHS'
s OCF Yield % Range Over the Past 10 Years
Min: 0.99 Med: 2.97 Max: 15.66
Current: 15
During the past 8 years, the highest OCF Yield % of PT Bundamedik Tbk was 15.66%. The lowest was 0.99%. And the median was 2.97%.
ISX:BMHS's OCF Yield % is ranked better than 81.35% of 681
companies
in the Healthcare Providers & Services industry
Industry Median: 5.44
vs ISX:BMHS: 15.00
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
PT Bundamedik Tbk OCF Yield % Related Terms
PT Bundamedik Tbk OCF Yield % Historical Data
* Premium members only.
The historical data trend for PT Bundamedik Tbk's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, PT Bundamedik Tbk's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Bundamedik Tbk OCF Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PT Bundamedik Tbk's OCF Yield % distribution charts can be found below:
* The bar in red indicates where PT Bundamedik Tbk's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Bundamedik Tbk (ISX:BMHS) has a OCF Yield % of 15.00 as of Jul. 06, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on PT Bundamedik Tbk and its competitors. This is 405% above median its historical median of 2.97. Over the past decade, PT Bundamedik Tbk's OCF Yield % has ranged from 0.99 to 15.66. According to the industry distribution chart, PT Bundamedik Tbk ranks #127 out of 681 companies in the Healthcare Providers & Services industry, placing it in the top 18.6%.
Is PT Bundamedik Tbk's OCF Yield % too high?
PT Bundamedik Tbk's current OCF Yield % of 15.00 is 405% above median its 10-year median of 2.97. Over the past 10 years, this metric has ranged from a low of 0.99 to a high of 15.66. The Healthcare Providers & Services industry median OCF Yield % is 5.44. PT Bundamedik Tbk's value of 15.00 is 175.7% above this industry median. Based on the distribution chart, PT Bundamedik Tbk ranks #127 out of 681 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, PT Bundamedik Tbk has a GF Score™ of 60/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does PT Bundamedik Tbk's OCF Yield % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PT Bundamedik Tbk ranks #127 out of 681 companies for OCF Yield %. This places PT Bundamedik Tbk in the top 19% of its industry — outperforming the majority of peers. The industry median OCF Yield % is 5.44. PT Bundamedik Tbk's value of 15.00 is 175.7% above this benchmark. Historically, PT Bundamedik Tbk's own OCF Yield % has ranged from 0.99 to 15.66 over the past decade. While the company's 10-year median is 2.97 vs. the industry median of 5.44, PT Bundamedik Tbk has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Healthcare Providers & Services company?
The median OCF Yield % among Healthcare Providers & Services companies is 5.44, based on 681 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Bundamedik Tbk's current OCF Yield % of 15.00 is 175.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on PT Bundamedik Tbk and its competitors. For the Healthcare Providers & Services industry, the median OCF Yield % is 5.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Bundamedik Tbk's current OCF Yield % is 15.00, which is 405% above median its own 10-year median of 2.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Bundamedik Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Bundamedik Tbk (ISX:BMHS) is currently considered Possible Value Trap. The stock's GF Value™ is Rp306.02, compared to a current price of Rp174.00 — trading 43.1% below its estimated fair value. The current OCF Yield % is 15.00, which is 405% above median its 10-year median of 2.97 and 175.7% above the Healthcare Providers & Services industry median of 5.44. PT Bundamedik Tbk's overall GF Score™ is 60/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For PT Bundamedik Tbk (ISX:BMHS), the current OCF Yield % is 15.00 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Bundamedik Tbk (ISX:BMHS) Overvalued in 2026?
Based on GuruFocus' analysis, PT Bundamedik Tbk stock appears to be undervalued.
The current stock price of Rp174.00 is trading 43.1% below its estimated GF Value™ of Rp306.02.
GuruFocus considers PT Bundamedik Tbk to be Possible Value Trap.
Key valuation signals for ISX:BMHS:
OCF Yield %: 15.00 (405% above median its 10-year median of 2.97)
GF Value™: Rp306.02 vs. price of Rp174.00 (43.1% below fair value)
Industry Position: 175.7% above the Healthcare Providers & Services median (#127 of 681)
No single metric tells the full story. See the ISX:BMHS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Bundamedik Tbk is a healthcare service provider. The Company carries out its main business activities through private hospital activities. It offers maternal and child health services, outpatient services, inpatient services, emergency services, service excellence centers, IVF services, and Clinical laboratory services.
60GF Score
Get the complete analysis for ISX:BMHS
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:BMHS has been successfully added to your 
